Fig. 1
From: Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung

Computed tomography and positron emission tomography before the treatment
From: Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
Computed tomography and positron emission tomography before the treatment